Eurobio Scientific Société anonyme (ALERS.PA)
EUR 24.92
(2.74%)
EUR 24.92
(2.74%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 315.81 Million EUR | -4.42% |
| 2022 | 330.41 Million EUR | 57.92% |
| 2021 | 209.22 Million EUR | 21.43% |
| 2020 | 172.29 Million EUR | 112.7% |
| 2019 | 81 Million EUR | 15.89% |
| 2018 | 69.89 Million EUR | -2.34% |
| 2017 | 71.57 Million EUR | 124.46% |
| 2016 | 31.88 Million EUR | -10.71% |
| 2015 | 35.71 Million EUR | -11.81% |
| 2014 | 40.49 Million EUR | 21.2% |
| 2013 | 33.41 Million EUR | -13.2% |
| 2012 | 38.49 Million EUR | 118.68% |
| 2011 | 17.6 Million EUR | -43.69% |
| 2010 | 31.26 Million EUR | -14.47% |
| 2009 | 36.54 Million EUR | 22.45% |
| 2008 | 29.84 Million EUR | -20.6% |
| 2007 | 37.58 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 313.76 Million EUR | 0.0% |
| 2023 Q2 | 312.76 Million EUR | 0.0% |
| 2023 FY | 315.81 Million EUR | -4.42% |
| 2023 Q4 | 315.81 Million EUR | 0.0% |
| 2022 Q4 | 330.41 Million EUR | 0.0% |
| 2022 FY | 330.41 Million EUR | 57.92% |
| 2022 Q2 | 213.83 Million EUR | 0.0% |
| 2021 Q4 | 209.22 Million EUR | 0.0% |
| 2021 FY | 209.22 Million EUR | 21.43% |
| 2021 Q2 | 178.31 Million EUR | 0.0% |
| 2020 FY | 172.29 Million EUR | 112.7% |
| 2020 Q4 | 172.29 Million EUR | 0.0% |
| 2020 Q2 | 118.26 Million EUR | 0.0% |
| 2019 Q2 | 71.36 Million EUR | 0.0% |
| 2019 Q4 | 81 Million EUR | 0.0% |
| 2019 FY | 81 Million EUR | 15.89% |
| 2018 Q4 | 69.89 Million EUR | 0.0% |
| 2018 FY | 69.89 Million EUR | -2.34% |
| 2018 Q2 | 66.22 Million EUR | 0.0% |
| 2017 Q4 | 71.57 Million EUR | 0.0% |
| 2017 FY | 71.57 Million EUR | 124.46% |
| 2017 Q2 | 71.07 Million EUR | 0.0% |
| 2016 Q4 | 31.88 Million EUR | 0.0% |
| 2016 Q2 | 31.16 Million EUR | 0.0% |
| 2016 FY | 31.88 Million EUR | -10.71% |
| 2015 FY | 35.71 Million EUR | -11.81% |
| 2015 Q4 | 35.71 Million EUR | 0.0% |
| 2015 Q2 | 39.28 Million EUR | 0.0% |
| 2014 Q4 | 40.49 Million EUR | 0.0% |
| 2014 FY | 40.49 Million EUR | 21.2% |
| 2014 Q2 | 43.18 Million EUR | 0.0% |
| 2013 Q2 | 35.88 Million EUR | 0.0% |
| 2013 FY | 33.41 Million EUR | -13.2% |
| 2013 Q4 | 33.41 Million EUR | 0.0% |
| 2012 Q4 | 38.49 Million EUR | 300.0% |
| 2012 Q1 | 9.62 Million EUR | -45.33% |
| 2012 FY | 38.49 Million EUR | 118.68% |
| 2012 Q2 | 16.18 Million EUR | 68.21% |
| 2012 Q3 | 9.62 Million EUR | -40.55% |
| 2011 Q1 | 4.4 Million EUR | -85.92% |
| 2011 FY | 17.6 Million EUR | -43.69% |
| 2011 Q4 | 17.6 Million EUR | 300.0% |
| 2011 Q3 | 4.4 Million EUR | -83.51% |
| 2011 Q2 | 26.69 Million EUR | 506.51% |
| 2010 Q1 | 7.81 Million EUR | -78.62% |
| 2010 Q2 | 38.61 Million EUR | 394.15% |
| 2010 Q3 | 7.81 Million EUR | -79.76% |
| 2010 Q4 | 31.26 Million EUR | 300.0% |
| 2010 FY | 31.26 Million EUR | -14.47% |
| 2009 Q4 | 36.54 Million EUR | 300.0% |
| 2009 Q3 | 9.13 Million EUR | 0.0% |
| 2009 Q2 | 9.13 Million EUR | 0.0% |
| 2009 Q1 | 9.13 Million EUR | 22.45% |
| 2009 FY | 36.54 Million EUR | 22.45% |
| 2008 Q3 | 7.46 Million EUR | 0.0% |
| 2008 Q1 | 7.46 Million EUR | -20.6% |
| 2008 Q2 | 7.46 Million EUR | 0.0% |
| 2008 FY | 29.84 Million EUR | -20.6% |
| 2008 Q4 | 7.46 Million EUR | 0.0% |
| 2007 Q2 | 9.39 Million EUR | 0.0% |
| 2007 FY | 37.58 Million EUR | 0.0% |
| 2007 Q1 | 9.39 Million EUR | 0.0% |
| 2007 Q4 | 9.39 Million EUR | 0.0% |
| 2007 Q3 | 9.39 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Affluent Medical SA | 56.62 Million EUR | -457.75% |
| Bluelinea Société Anonyme | 13.16 Million EUR | -2298.948% |
| Carmat SA | 53.06 Million EUR | -495.103% |
| Diagnostic Medical Systems S.A. | 51.13 Million EUR | -517.574% |
| Euromedis Groupe | 46.25 Million EUR | -582.719% |
| Ikonisys S.A. | 20.85 Million EUR | -1414.512% |
| Implanet S.A. | 10.63 Million EUR | -2869.023% |
| Median Technologies SA | 35.81 Million EUR | -781.869% |
| SpineGuard SA | 11.03 Million EUR | -2761.849% |
| Theraclion SA | 18.66 Million EUR | -1592.147% |
| Euroapi S.A. | 1.61 Billion EUR | 80.413% |
| Guerbet SA | 1.02 Billion EUR | 69.196% |